MICHAEL LONG:
 
MICHAEL LONG:




 
 
 
 
 
President and CEO, Velcura Therapeutics in Ann Arbor. Long has served as a consultant for startup and leading biotechnology firms as well as major pharmaceutical firms, particularly in the areas of refining and troubleshooting their discovery research efforts. He worked extensively with a later stage biotechnology company to improve its scientific presentations in preparation for an IPO and played a role in the company’s subsequent acquisition–valued in excess of $500 million. Long’s organizational management experience includes the direction of large for-profit clinical laboratories. He has worked in the area of cell and molecular biology for more than three decades and received more than $12 million in funding for his research from the National Institutes of Health (NIH) prior to founding Velcura. He was a professor for 20 years at the University of Michigan and the inventor on 12 patents that the university exclusively licensed to Velcura, as well as two recent patents for Velcura. Long served on multiple national grant review committees at the NIH and has reviewed grant applications for the American Cancer Society and other national organizations. He has been a reviewer for Science, Nature, Nature Biotechnology, and many other scientific publications. Long received his bachelor’s degree in biology and master’s and PhD degrees in human physiology from Wayne State University School of Medicine. He completed a post-doctoral fellowship at the Sloan Kettering Memorial Cancer Center and sabbatical training in the laboratory at one of the Howard Hughes Medical Institute laboratories. He also has 27 years of volunteer experience with the nonprofit Leukemia and Lymphoma Society; he served six years on its executive committee and now is a director of this $300 million organization.


WHERE BORN: "Detroit."

MOST INFLUENTIAL PERSONS: "A physican named Julius Rutzky and many postdoctoral mentors. Rutzky taught me a lot about research in leukemias. Postdoctoral mentors taught me how to think correctly about science and how to frame and evaluate scientific questions."

LAST BOOK READ: "I read about two books a week. The last one I reread was Jim Collins' Good to Great. And on the fiction side, Stone Cold by David Baldacci."

WORDS THAT DESCRIBE ME: "Motivated, driven, goal-oriented, focused."

WHERE MY FIELD/INDUSTRY IS HEADED: "We’re a biotech firm. Life sciences in general and biotech in particular are growing strongly and are going to provide a lot of novel and therapeutic devices to cure diseases. It’s a very exciting time to be in the field."

FAVORITE TECHNOLOGICAL GADGET: "I don’t think I have a favorite. I’m immersed in technology and use it as an everyday thing. All IT-related technology is fascinating."

FAVORITE PLACE: "In Michigan, the Charlevoix area. Outside of Michigan, I love San Diego."

FAVORITE HOBBIES: "Sailing."

FAVORITE FOOD: "French, continental. Those are at the top of my list."

MY HIDDEN TALENT: "I’m a martial artist. I have one black belt, and I’m working on a second one."

HOW I WANT TO BE REMEMBERED: "As someone who had an impact on providing therapies for disease, bone diseases in particular."

At the annual awards reception in May 2015, one Leader & Innovator from the previous 12 months will be selected as the Leader & Innovator of the Year.